07:20 AM EDT, 05/01/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) announce a proposed plan by its subsidiary, LLT Management, for the final resolution of all current and future claims tied to ovarian cancer stemming from cosmetic talc litigation against it and its affiliates in the US.
Price: 147.57, Change: +2.98, Percent Change: +2.06